Probiotics, prebiotics and child health: Where are we going?

Journal of International Medical Research

Volumn 32, Issue 2, 2004, Pages 97-108

  Salvini, F ^a   Granieri, L ^a   Gemmellaro, L ^a   Giovannini, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Allergy; Child health; Children; Immunity; Prebiotics; Probiotics; Review

Indexed keywords

ANTIBIOTIC AGENT; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; GLYCOPROTEIN; LACTADHERIN; OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ACUTE DIARRHEA; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BIFIDOBACTERIUM; CHILD; CHILD HEALTH; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG TARGETING; ENTERITIS; FOOD ALLERGY; GASTROINTESTINAL INFECTION; GROWTH INHIBITION; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LONG TERM CARE; RESPIRATORY TRACT INFECTION; REVIEW; URINARY TRACT INFECTION;

EID: 1642528445     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000403200201     Document Type: Review

References (61)

1. Simon GL, Gorbach SL: The human intestinal microflora. Dig Dis Sci 1986; 31 (9 Suppl): 147S - 162S.
2. Roberfroid MB, Bornet F, Bouley C, Cummings JH: Colonic microflora: Nutrition and health. Summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr Rev 1995; 53: 127 - 130.
3. Fuller R: Probiotics in human medicine. Gut 1991; 32: 439 - 442.
4. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, et al: Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80 (Suppl 1): S147 - S171.
5. Diplock AT, Aggett PJ, Ashwell M, Bornet F, Fern EF, Roberfroid MB: Scientific concepts of functional foods in Europe: consensus document. Br J Nutr 1999; 81 (Suppl 1): S1 - S27.
6. de Vrese M, Schrezenmeir J: Probiotics and non-intestinal infectious conditions. Br J Nutr 2002; 88 (Suppl 1): S59 - S66.
7. Ouwehand A, Sutas Y, Salminen S, Isolauri E: Probiotic therapies: Present and future. Int Semin Pediatr Gastroenterol Nutr 1998; 7: 7 - 15.
8. Kirjavainen PV, Ouwehand AC, Isolauri E, Salminen SJ: The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol Lett 1998; 167: 185 - 189.
9. Mestecky J, McGhee JR: Prospects for human mucosal vaccines. Adv Exp Med Biol 1992; 327: 13-23.
10. Czerkinsky C, Svennerholm AM, Holmgren J: Induction and assessment of immunity at enteromucosal surfaces in humans: Implications for vaccine development. Clin Infect Dis 1993; 16 (Suppl 2): S106 - S116.
11. Neutra MR, Frey A, Kraehenbuhl JP: Epithelial M cells: gateways for mucosal infection and immunization. Cell 1996; 86: 345 - 348.
12. Cebra JJ, Schrader CE, Shroff KE, Weinstein PD: Are Peyer's patch germinal centre reactions different from those occurring in other lymphoid tissues? Res Immunol 1991; 142: 222 - 226.
13. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S: Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992; 37: 121 - 128.
14. Silva M, Jacobus NV, Deneke C, Gorbach SL: Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987; 31: 1231 - 1233.
15. Wilson KH, Perini F: Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 1988; 56: 2610 - 2614.
16. Bernet MF, Brassart D, Neeser JR, Servin AL: Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35: 483 - 489.
17. Rigothier MC, Maccario J, Gayral P: Inhibitory activity of Saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro. Parasitol Res 1994; 80: 10 - 15.
18. Pothoulakis C, Kelly CP, Joshi MA, Gao N, O'Keone CJ, Castagliuolo I, et al: Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993; 104: 1108 - 1115.
19. Czrucka D, Roux I, Rampal P: Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3′,5′-cyclic monophosphate induction in intestinal cells. Gastroenterology 1994; 106: 65 - 72.
20. Kaila M, Isolauri E, Soppi F, Virtanen E, Laine S, Arvilommi H: Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992; 32: 141 - 144.
21. Majamaa H, Isolauri E, Saxelin M, Vesikari I: Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995; 20: 333 - 338.
22. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA: Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276: G941 - G950.
23. Szajewska H, Mrukowicz JZ: Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: A systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 2001; 33 (Suppl 2): S17 - S25.
24. Pedone CA, Bernabeu AO, Postaire ER, Bouley CF, Reinert P: The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int J Clin Pract 1999; 53: 179 - 184.
25. Pedone CA, Arnaud CC, Postaire ER, Bouley CF, Reinert P: Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int J Clin Pract 2000; 54: 568 - 571.
26. Yasui H, Kiyoshima J, Ushijima H: Passive protection against rotavirus-induced diarrhea of mouse pups born to and nursed by dams fed Bifidobacterium breve YIT4064. J Infect Dis 1995; 172: 403 - 409.
27. Solis P, Lemmonier D: Induction of human cytokines by bacteria used in dairy foods. Nutr Res 1993; 13: 1127 - 1140.
28. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM: Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 1994; 10: 55 - 63.
29. Vanderhoof JA, Young RJ: Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr 1998; 27: 323 - 332.
30. Gupta P, Andrew H, Kirschner BS, Guandalini S: Is Lactobacillus GG helpful in children with Crohn's disease? Result of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 2000; 31: 453 - 457.
31. Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T: Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 2003; 22: 56 - 63.
32. Matsuda H, Fujiyama Y, Andoh A, Ushijima T, Kajinami T, Bomba T: Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J Gastroenterol Hepatol 2000; 15: 61 - 68.
33. Bamba T, Matsuda H, Endo M, Fujiyama Y: The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis. J Gastroenterol 1995; 30 (Suppl 8): 45 - 47.
34. Pelto L, Isolauri E, Lilius EM, Nuutila J, Salminen S: Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin Exp Allergy 1998; 28: 1474 - 1479.
35. Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E: New aspects of probiotics - a novel approach in the management of food allergy. Allergy 1999; 54: 909 - 915.
36. Dugas B, Mercenier A, Lenoir-Wijnkoop I, Arnaud C, Dugas N, Postaire E: Immunity and probiotics. Immunol Today 1999; 20: 387 - 390.
37. Hessle C, Hanson LA, Wold AE: Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol 1999; 116: 276 - 282.
38. Sepp E, Julge K, Vasar M, Naaber P, Bjorksten B, Mikelsaar M: Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 1997; 86: 956-961.
39. MajamaA H, Isolauri E: Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99: 179 - 185.
40. Isolauri E: Studies on Lactobacillus GG in food hypersensitivity disorders. Nutr Today 1996; 31 (6 Suppl 1): 28S - 31S.
41. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S: Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30: 1604 - 1610.
42. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E: Probiotics in primary prevention oA atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357: 1076 - 1079.
43. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al: Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: Randomized, placebo, controlled trial. FEMS Immunol Med Microbiol 2003; 35: 131 - 134.
44. Gluck U, Gebbers JO: Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 2003; 77: 517 - 520.
45. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, et al: Effect of long term consumption of probiotic milk on infections in children attending day care centres: Double blind, randomised trial. BMJ 2001; 322: 1327.
46. Cunningham-Rundles S, Ahrne S, Bengmark S, Johann-Liang R, Marshall F, Metakis L, et al: Probiotics and immune response. Am J Gastroenterol 2000; 95 (1 Suppl): S22 - S25.
47. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, et al: Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 2000; 30: 61 - 67.
48. Newburg DS, Neubauer SH: Carbohydrates in Milk. San Diego: Academic Press, 1995; pp273 - 349.
49. Stahl B, Thurl S, Zeng J, Karas M, Hillenkamp F, Steup M, et al: Oligosaccharides from human milk as revealed by matrix-assisted laser desorption/ionization mass spectrometry. Anal Biochem 1994; 223: 218 - 226.
50. Schley PD, Field CJ: The immune-enhancing effects of dietary fibres and prebiotics. Br J Nutr 2002; 87 (Suppl 2): S221 - S230.
51. Buddington RK, Kelly-Quagliana K, Buddington KK, Kimura Y: Non-digestible oligosaccharides and defence functions: Lessons learned from animal models. Br J Nutr 2002; 87 (Suppl 2): S231 - S239.
52. Andersson B, Porras O, Hanson LA, Lagergard T, Svanborg-Eden C: Inhibition of attachment of Streptococcus pneumoniae and Haemophilus influenzae by human milk and receptor oligosaccharides. J Infect Dis 1986; 153: 232 - 237.
53. Cervantes LE, Soto L, Newburg DS, Ruitz-Palacios GM: Campylobacter jejuni receptor analogues present in human milk. Microb Ecol Health Dis 1991; 4: S27.
54. Cleary TG, Chambers JP, Pickering LK: Protection of suckling mice from the heat-stable enterotoxin of Escherichia coli by human milk. J Infect Dis 1983; 148: 1114 - 1119.
55. Boehm G, Lidestri M, Cosetta P, Jelinek J, Negretti F, Stahl B, et al: Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed 2002; 86: F178 - F181.
56. Moro G, Minoli I, Mosca M, Fanaro S, Jelinek J, Stahl B, et al: Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr 2002; 34: 291 - 295.
57. Savino F, Cresi F, Maccario S, Cavallo F, Dalmasso P, Fanaro S, et al: 'Minor' feeding problems during the first months of life: effect of a partially hydrolysed milk formula containing fructo- and galacto-oligosoccharides. Acta Paediatr 2003; 441: 86 - 90.
58. Dehnalek MIK, Ostram KM, Hilry MD: Use of undigestible oligosaccharides to prevent and treat diarrhea. International application published under the Patent Cooperation Treaty Number W0 97/02829, 1997.
59. Newburg D: Oligosacccharides in human milk and bacterial colonization. J Pediatr Gastroenterol Nutr 2000; 30 (Suppl 2): S8 - S17.
60. Isolauri E. Probiotics and gut inflammation. Curr Opin Gastroenterol 1999; 15: 534 - 537.
61. Fisberg M, Maulen I, Vasquez E, Garcia J, Comer GM, Alarvon PA: Effect of oral supplementation with and without symbiotics on catch-up growth in preschool children. J Pediatr Gastroenterol Nutr 2000; 31 (Suppl 2): Abstract 987.